NTLA · Intellia Therapeutics, Inc.
Market Cap
$1.84B
Shares
140.13M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-06-15 | 2026-06-13 | |
| 8-K | 2026-06-10 | 2026-06-09 | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-30 | 2026-06-09 | |
| 8-K | 2026-04-30 | 2026-04-27 | |
| 8-K | 2026-04-27 | — | |
| 8-K | 2026-04-10 | 2026-04-07 | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-11-10 | 2025-11-08 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-09-25 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-16 | 2025-06-15 | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-19 | 2025-05-18 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-30 | 2025-06-11 | |
| 8-K | 2025-04-07 | 2025-04-03 | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-21 | 2025-02-18 | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 8-K | 2024-11-18 | 2024-11-16 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-25 | 2024-10-24 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-26 | 2024-06-21 | |
| 8-K | 2024-06-14 | 2024-06-12 | |
| 8-K | 2024-06-13 | 2024-06-12 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-29 | 2024-06-12 | |
| 8-K | 2024-04-15 | 2024-04-10 | |
| 8-K | 2024-03-22 | 2024-03-19 | |
| 8-K | 2024-02-23 | — |
Showing 1–50 of 131 filings
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
278 filings
266 filers
Visit website
Investor relations